FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.22-SNAPSHOT | FHIR Version n/a User: [n/a]

708828000: Elvitegravir (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Integrase strand transfer inhibitor\Elvitegravir (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Quinoline\Quinolone (substance)\Elvitegravir (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Halogen and/or halogen compound\Chlorine and/or chlorine compound\Chlorine compound\Organic chloride compound\Chlorinated hydrocarbon\Chlorobenzene\Elvitegravir (substance)
\Halogen and/or halogen compound\Halogenated hydrocarbon\Chlorinated hydrocarbon\Chlorobenzene\Elvitegravir (substance)

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Quinolone (substance)\Elvitegravir (substance)

\Organic compound\Substance with ether structure\Elvitegravir (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinoline\Quinolone (substance)\Elvitegravir (substance)
\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Quinolone (substance)\Elvitegravir (substance)
\Organic compound\Organic chloride compound\Chlorinated hydrocarbon\Chlorobenzene\Elvitegravir (substance)
\Organic compound\Hydrocarbon\Halogenated hydrocarbon\Chlorinated hydrocarbon\Chlorobenzene\Elvitegravir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Elvitegravir (substance)	Is a	Integrase strand transfer inhibitor	true	Inferred relationship	Some
Elvitegravir (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Integrase strand transfer inhibitor (disposition)	true	Inferred relationship	Some
Elvitegravir (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Elvitegravir (substance)	Is a	Quinolone (substance)	true	Inferred relationship	Some
Elvitegravir (substance)	Is a	éther	false	Inferred relationship	Some
Elvitegravir (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Elvitegravir (substance)	Is a	Nucleotidyltransferase inhibitor	false	Inferred relationship	Some
Elvitegravir (substance)	Is a	Chlorobenzene	true	Inferred relationship	Some
Elvitegravir (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing elvitegravir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Elvitegravir (substance)	Inferred relationship	Some	1
Elvitegravir-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Elvitegravir (substance)	Inferred relationship	Some	1
Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Elvitegravir (substance)	Inferred relationship	Some	3
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Elvitegravir (substance)	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Elvitegravir (substance)	Inferred relationship	Some	6
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Elvitegravir (substance)	Inferred relationship	Some	6
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Elvitegravir (substance)	Inferred relationship	Some	2
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Elvitegravir (substance)	Inferred relationship	Some	2
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Elvitegravir (substance)	Inferred relationship	Some	3
Elvitegravir only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Elvitegravir (substance)	Inferred relationship	Some	1
Product containing only elvitegravir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Elvitegravir (substance)	Inferred relationship	Some	1
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Elvitegravir (substance)	Inferred relationship	Some	3

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3037314016	Elvitegravir (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3037322011	Elvitegravir	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
53741000195119	elvitegravir	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
808321000172116	elvitégravir	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
68671000195115	Elvitegravir	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module